Imbio PHA (4.0.0) vs LINQ II Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Imbio PHA (4.0.0)

by Imbio (a subsidiary of 4DMedical)

LINQ II Insertable Cardiac Monitor

by Medtronic

AI Verdict

Tool A is an AI-powered software that analyzes CT pulmonary angiogram (CTPA) scans to measure cardiac structures, aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension. In contrast, Tool B is an AI-powered insertable cardiac monitor designed for long-term, continuous heart rhythm monitoring to diagnose arrhythmias. While both utilize AI in cardiology, they serve distinct diagnostic purposes and employ different data modalities (imaging vs. continuous electrical monitoring).

Choose Imbio PHA (4.0.0) if…

Choose Imbio PHA (4.0.0) if you require rapid, automated, and objective assessment of cardiac structures from existing CT pulmonary angiogram (CTPA) scans. This tool is ideal for aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension by providing precise measurements of right ventricular dilation and pulmonary artery dimensions.

View Imbio PHA (4.0.0) →

Choose LINQ II Insertable Cardiac Monitor if…

Choose the Medtronic LINQ II Insertable Cardiac Monitor if your patient requires long-term, continuous heart rhythm monitoring for the diagnosis of infrequent or paroxysmal arrhythmias. This device offers up to 4.5 years of monitoring with AI-powered accuracy and remote management capabilities, making it suitable for comprehensive arrhythmia detection over an extended period.

View LINQ II Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Imbio PHA (4.0.0)	LINQ II Insertable Cardiac Monitor
Deployment	Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel).	Subcutaneous implant with remote monitoring via mobile app or home communicator.
FDA Status	Yes AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Imbio PHA (4.0.0)	LINQ II Insertable Cardiac Monitor
Product Name	Imbio PHA (4.0.0)	LINQ II Insertable Cardiac Monitor
Product Type	AI-powered medical image processing software	AI-powered insertable cardiac monitor
Company	Imbio	Medtronic
Primary Medical Specialties	Cardiology, Pulmonology, Radiology	Cardiology
Core AI Function	Automated measurement of cardiac structures (ventricle, pulmonary artery, aorta diameters) and ratio calculations from CTPA scans.	Enhanced accuracy for diagnosing arrhythmias (AccuRhythmu2122 AI algorithms), innovative PVC detection.
Monitoring/Assessment Capability	Rapid, fully-automated assessment (typically in minutes) of CTPA scans.	Up to 4.5 years of continuous heart rhythm monitoring.

Videos

Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and LINQ II Insertable Cardiac Monitor.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the fundamental difference in how these tools acquire and process patient data?

Imbio PHA processes existing CT pulmonary angiogram (CTPA) scans to measure cardiac structures. In contrast, the LINQ II Insertable Cardiac Monitor is an implanted device that continuously monitors heart rhythms internally for an extended period.

For what primary clinical conditions are these tools designed to assist in diagnosis or management?

Imbio PHA aids in the diagnosis and risk stratification of pulmonary embolism and hypertension by assessing right ventricular dilation from CTPA scans. The Medtronic LINQ II is designed for long-term, continuous heart rhythm monitoring to diagnose arrhythmias.

How do the AI capabilities of each tool differ in their application?

Imbio PHA utilizes AI algorithms for automated anatomical identification and measurement of cardiac structures from images. The Medtronic LINQ II employs AccuRhythmu2122 AI algorithms for enhanced accuracy in detecting and diagnosing arrhythmias, including an innovative PVC detection algorithm.

What is the typical duration or frequency of monitoring or assessment provided by each tool?

Imbio PHA provides a rapid, fully-automated assessment of CTPA scans, typically in minutes, for on-demand analysis. The Medtronic LINQ II offers long-term, continuous heart rhythm monitoring for up to 4.5 years from implantation.

What kind of output or reports do these tools generate for clinical review?

Imbio PHA generates annotated DICOM images and provides summary reports in PDF format. The Medtronic LINQ II transmits continuous heart rhythm data via its mobile app or home communicator for review.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform